Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer (NSCLC)

Explore clinical trials studying Non-small Cell Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

145 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer (NSCLC) trial results

Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

NCT07223047

Conditions
Advanced Solid Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • NEXT Oncology San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
  • NEXT Virginia Fairfax, Virginia, United States
View Trial Details
Recruiting

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

NCT06567015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sarah Cannon Research Institute (SCRI) (The SCRI Oncology Research Consortium) Nashville, Tennessee, United States
  • Oncology Consultants (OC) - Texas Medical Center - Cancer Center Houston, Texas, United States
  • Shanghai East Hospital, Tongji University Shanghai, China
  • Tianjin Medical University Cancer Institute and Hospital Tianjin, China
View all 16 locations
View Trial Details
Recruiting

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

NCT07154706

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Los Angeles, California, United States
  • UCI Chao Family Comprehensive Cancer Center Orange, California, United States
  • Georgetown University Medical Cener (GUMC) Washington D.C., District of Columbia, United States
  • Advent Health Orlando, Florida, United States
View all 33 locations
View Trial Details
Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT05379985

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +45 more
Locations
  • UC Irvine/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCLA Santa Monica, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
View all 21 locations
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 85 locations
View Trial Details
Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

NCT05985655

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START San Antonio San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View all 13 locations
View Trial Details
Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

Conditions
Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
Locations
  • City of Hope Duarte, California, United States
  • UC IRVINE Health Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 53 locations
View Trial Details
Recruiting

Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients

NCT06114108

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Kantonspital Aarau Aarau, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
  • Kantonsspital Graubuenden Chur, Switzerland
  • Hôpital Fribourgeois - Hôpital Cantonal Fribourg, Switzerland
View Trial Details

Related conditions